Abstract This paper provides an analysis on the use of 15D and EQ-5D to measure health related quality of life. Measures like these are often used interchangeably in costeffectiveness studies. However, it is unclear whether they measure the same level of health in the same patients. The empirical performance of the two multi-attribute utility instruments is tested in terms of feasibility, utility score, linear relationship and agreement by using a novel Norwegian data set. The paper also includes an analysis of how the instruments rank individuals in terms of health status, and their discriminatory power are tested. The results show that EQ-5D and 15D should not be used interchangeably in economic evaluations. EQ-5D is likely to give a more favourable cost utility ratio than 15D. The utility scores generated from the two instruments differ significantly different from each other, even though they correlate well.
Introduction
The use of quality-adjusted life years (QALYs) as an outcome measure in economic evaluation enables comparisons among the cost-effectiveness of diverse healthcare interventions. This comparability is considered one of the main advantages of cost utility analysis. However, the comparability of these analyses may be jeopardised because of the diverse approaches, or different instruments, used to elicit health utility. Health utility can be elicited directly or indirectly. When using standard techniques, such as time trade-off (TTO) or standard gamble (SG), patients' preferences for health are measured directly. Questionnaires that incorporate preference weights from, for example, community members, measures health utility of different patients indirectly. Ranges of such questionnaires, often named multi-attribute utility (MAU) instruments, or preference-based measures, have been developed that are used frequently as outcome measure in costeffectiveness studies. MAU instruments consist of two interrelated components that vary from instrument to instrument. The first component is a health state descriptive system, and the second is a system of utility weights. The utility weights are used to convert the descriptive system into a summary index score. Thus far, there is no gold standard, and there are few guidelines regarding which instrument is the most appropriate one to use, and how the system of utility weights should be developed. The varied use of these instruments and value sets could have significant implications for the estimated QALY gains in economic evaluations and, thus, also for the comparability of different analyses. Lack of empirical evidence may be one reason why there is no gold standard.
In this paper, we focus on EQ-5D and 15D, two of the many MAU instruments. Our main objective is to assess whether EQ-5D and 15D can be used interchangeably in cost utility analysis. More precisely, we sought to determine whether the effectiveness of an intervention measured by EQ-5D utilities could be compared with the effectiveness of an intervention measured with 15D utilities. Is it likely that one of the instruments will give a more favourable cost utility ratio than another? In an earlier review, Brazier et al. [3] concluded that we need head-tohead comparisons of different MAUs across a range of conditions and severity levels in order to assess the implications for the interpretation and comparability of economic analyses. In the previous literature, there has been a great deal of focus on the comparative performances of EQ-5D and SF-6D [1, 4, 11, 12, 15] . However, not much emphasis has been placed on empirical evidence of the comparative performances of EQ-5D and 15D. 15D and EQ-5D are quite different from each other in their measurement characteristics. 15D seems to have a very rich and sensitive descriptive system, covering more aspects of health than EQ-5D. EQ-5D seems to have a poor descriptive system, not covering many aspect of health-related quality of life (HRQoL). Nevertheless, EQ-5D is one of the most frequently used instruments. It is, for instance, recommended for use in cost-effectiveness analyses by the National Institute of Health and Clinical Excellence (NICE) in the UK and by the health care insurance board in the Netherlands. A range of utility weights has been developed for EQ-5D; however, only one value set is typically explored in comparative EQ-5D studies. We are therefore also interested in determining whether different value sets in EQ-5D make any difference to comparative performance. Several approaches can be used for the valuation of health preferences in the development of scoring algorithms. However, there is no agreement on what methods one should use. We therefore use two scoring algorithms for EQ-5D in the comparisons: one based on TTO, and the other based on a visual analogue scale.
We analyse and compare the empirical performances of the two instruments by using a novel Norwegian data set on HRQoL in post-stroke patients. We are well aware that the instruments have different utility scales. From earlier studies comparing EQ-5D and 15D, we know that 15D tends, in general, to give a slightly higher mean and median utility score than EQ-5D. However, as long as individuals are ranked equally after utility scoring, the difference in scale may not be a problem. On the other hand, there will be difficulties with interchangeable use if one instrument gives an individual a highly ranked utility score, while another gives the same individual a poorly ranked score. An additional task of this study, therefore, was to provide an analysis of how individuals are ranked by utility score. This analysis was conducted by rank regression. It is preferable that the instrument's scales have a strong linear relationship and good association. If the instruments detect the same differences in individuals with a certain health problem, then using the different scales may not be a problem, either. Another task of the study, therefore, was to assess the discriminatory power of the instruments.
The comparative performance of the two instruments is assessed in terms of feasibility and distribution of utility score and summary statistics. The ranking of patients' health status level by each instrument is investigated by using rank regression. The instruments' feasibility is analysed by looking at different response and completion rates. Because it is time-consuming and costly to gather HRQoL data, the feasibility of the instruments is important. A highly functional preference-based instrument should be easy to complete for all types of patients. Stroke victims may be paralysed or have cognitive impairments; as such, they may have difficulties completing such a questionnaire. The instruments' feasibility is analysed by looking at different response and completion rates.
Stroke is the most common cause of serious disability and need for long-term public healthcare services in Western societies [7, 9] . Annually, around 15 million people suffer from stroke worldwide. Five million of those individuals die, and another 5 million are left permanently disabled [13] . Previous studies have compared EQ-5D and 15D in relation to several diseases [14, 17, [19] [20] [21] ; however, this is the first study to investigate the comparative performances of EQ-5D and 15D when assessing healthrelated HRQoL among post-stroke patients. The importance of economic evaluations of stroke-related care and rehabilitation is likely to increase in the future, due to an aging population and the related increased incidence rates [9] . This will strain the healthcare system in terms of acute services, nursing and care, rehabilitation, and, consequently, the resources spent within this field.
The paper is structured as follows: the EQ-5D and 15D instruments are described briefly in the section ''15D and EQ-5D''. Patient recruitment, procedures, and description of the data and variables are presented under the section ''Methods''. We provide the results of the analysis in the section ''Results''-first, we look at the feasibility of the instruments, and then at the total utility scores and their properties. A ''Discussion'' of the findings is followed by ''Conclusions''.
15D and EQ-5D
EQ-5D consists of five attributes, which cover mobility, self-care, usual activity, pain/discomfort, and anxiety/ depression. Each attribute has three levels, ranging from 1 (indicating no problems) to 3 (indicating extreme problems). Through this instrument, 245 possible health states (including dead and unconscious) are defined. Several systems of country-specific utility weights (value sets) have been developed to assign scores to the defined health states in EQ-5D. Direct techniques, such as TTO and analogue visual scale (VAS), have been used to develop the different scoring algorithms. To explore the effect of different value sets in a comparative setting, we use two totally different sets. One is based on a TTO valuation while the other is based on a valuation done with a VAS. These are henceforth referred to as EQ-TTO and EQ-VAS. It is valuable to know whether a value set can make the two MAUs more alike. When EQ-TTO was developed, the TTO was applied to 2,997 adults in the UK to measure their health preferences for 43 different health states. However, each respondent valued no more than 13 hypothetical health states. They were given the opportunity to value them as worse as or better than being dead, and they valued each health state once. A generalised least-squares regression technique was used to derive the scoring function [6] . The model is additive, and the minimum possible score is negative (-0.59). When EQ-VAS was developed, 928 randomly selected healthy Finns valued hypothetical health states using VAS. A weighting for age and sex was conducted in the sample, due to an over-representation of the elderly. Each respondent valued a subset of 46 different health states (including dead and unconscious), with each stated as having a duration of 1 year. All health states were valued once, except for the best possible state (11111), the worst possible state (33333), and dead, which were valued twice. The final model used to derive an additive utility function is based on ordinary least square and logit transformation of the individual data [24] . The lowest possible score in this system is negative (-0.011). Using two value sets for EQ-5D, where one is based on TTO and another on VAS, strengthens our insight into the differences between EQ-5D and 15D and may help us find explanations.
The 15D instrument measures HRQoL using 15 different attributes: mobility, vision, hearing, breathing, sleeping, eating, speech, elimination, usual activities, mental function, discomfort/symptoms, depression, distress, vitality, and sexual function. Each attribute has five levels: level 1 (a situation with no problems) through level 5 (a situation with severe problems). Thus, 15D defines an enormous number of health states (5 15 ). A few sets of utility weights have been developed for 15D; the most commonly used are Finnish. However, there are two other available value sets, developed in Denmark and Greece. The Finnish value set, which was used in this study, is also based on a valuation of preferences for health outcomes using a VAS. However, the analogue scale used for this valuation is not identical to that used when the value set used for EQ-VAS was developed. The scale was a 0-100 ratio scale, with adjacent quantifiers, emphasising the nature of the ratio scale and explaining how the numbers on the scale should be interpreted. The valuation was completed by a representative sample of the Finnish adult population, through a threestage valuation procedure [18] . Respondents first indicated the relative importance of each dimension on the type of ratio scale the VAS mentioned, and then valued each level on each dimension (including dead and unconscious) in the same type of ratio scale. The scoring function is also additive; however, in contrast to the two selected EQ-5D value sets, the lowest possible score is 0.11.
Methods

Recruitment
At least 6 months after the onset of stroke, during the period January 2006 and February 2009, all surviving stroke patients 1 admitted to the stroke unit of a large Norwegian hospital 2 were sent a survey including HRQoL questionnaires. The reason for the 6-month time restriction was that the validity of the patients' own judgements of HRQoL could be doubtful, especially during the acute phase after stroke and significant changes in health conditions [25] . After the most acute phase, the health condition may be assumed to have stabilised. In order to reduce selection problems, all patients surviving at least 6 months after their stroke were included. Non-responders were sent a postal reminder at least 6 weeks after the first invitation. Patients' care givers were allowed to complete the questionnaire (with the agreement of the patient), due to the high rate of paralysis among stroke victims. Patients were categorised as disabled if they were not capable of completing the questionnaire themselves. A pilot study was carried out at the beginning of the survey. 3 Ethical approval was obtained from the regional committee for medical and health professional research ethics in Western Norway and from Norwegian Social Science Data Services.
Data and variables
All invited patients were asked to fill out a set of questionnaires, including both 15D and EQ-5D. All patients received exactly the same questionnaire. There was no randomisation in the ordering of the questionnaires' set up. 4 In addition to the HRQoL data from EQ-5D and 15D, information was collected regarding the patients' gender, age, marital status, education level, income level, occupational status, and body mass index (BMI). A range of health status indicators, such as self-assessed health, assessment of overall health using the VAS, and selfreported information regarding chronic diseases, functional problems, and pain were also included as part of the questionnaire. The survey also contained three different clinical measures: the Barthel Index (BI), the Fatigue Severity Scale (FSS), and the Hospital Anxiety and Depression Scale (HADS). These measures are used widely to identify common symptoms and health indicators in post-stroke patients. The survey was organised as follows:
(1) 15D questionnaire; (2) the section covering general information about the responders and their general health; (3) EQ-5D questionnaire; (4) HADS questionnaire; (5) FSS questionnaire; (6) BI questionnaire; and (7) the VAS. Based on the information in the questionnaire, the sample was separated into three age groups: (1) B66 years, (2) 67-79 years, and (3) C80. Marital status was separated into three categories: (1) married, (2) widowed, and (3) single. Education and income level were separated into two groups-those with a college or university degree were said to have higher education, and those who earned more than NOK; 5 500,000 annually were classified as high-income. Occupational status was separated into three groups: (1) employed, (2) retired, and (3) receivers of disability pension. Finally, BMI value was separated into four groups, in line with the World Health Organization's classification: (1) underweight (BMI \18.5), (2) normal range (BMI 18.5-24.99), (3) overweight (25 B BMI \ 30), and (4) obese (BMI C 30).
The self-assessed health question has five standard categories, which we collapsed into three categories: (1) very good or good health, (2) mediocre health, and (3) poor or very poor health. The VAS assessment of overall health is categorised into the following groups: (1) good VAS (C80), (2) severe VAS (C40 and \80), and (3) poor VAS (\40). We created binary variables for having any chronic diseases, functional problems, or pain, where 1 indicates severe or some problems related to these aspects, and 0 indicates no problems.
BI measures performance of daily activities related to mobility and self-care, and is categorised into three groups, following Sulter et al. [23] : (1) independent, with minimal assistance (BI C 85); (2) assisted independence (60 B BI \ 85); and (3) dependent (BI \ 60). Fatigue is measured by FSS [10] and indicated by a binary variable equal to 1 when fatigue is present. Anxiety and depression are measured by HADS [8] , and are categorised as a binary variable, where 1 indicates a definite case of depression or anxiety. We constructed a binary variable for each of the three types of stroke considered (ischemic, intracerebral haemorrhage, and subarachnoid haemorrhage). In addition, we include three variables indicating time elapsed, in months, since the stroke: (1) \ 12 months, (2) 12-18 months, and (3) [18 months. Table 1 provides descriptive statistics for all the variables outlined above.
Procedure
We investigated the feasibility of the instruments with the overall response rate of the survey and the completion rates for EQ-5D and 15D. The three sets of utility scores computed with the instruments were compared visually, by box plot, and by summary statistics. Differences between distributions were tested with a Kolmogorov-Smirnov test. Summary statistics were also reported for quintiles. Differences between scores were tested by using paired t tests and signed rank tests. The discriminatory power of each instrument was investigated with a test of construct validity 6 ; the validation was conducted by extreme groups and in line with Streiner et al. [22] . The association between the two instruments was measured by the intraclass correlation coefficient (ICC), Pearson correlations, and scatter plots. The ICC was derived from a two-way mixed model, with an absolute agreement definition and average measure, according to Shrout and Fleiss [16] . To check whether the individuals were ranked equally by each instrument, we estimated an ordinary least-square regression, with rank as the dependent variable, and the socioeconomic variables, health status, and clinical indicators as covariates. The effects of the covariates on the rank from each regression should not be significantly different if the individuals within each group have the same rank. We used standard statistical software (Intercooled Stata 10.1 or SPSS 15) for all analyses. P values less than 0.05 were defined as statistically significant.
Results
Feasibility
Of the 698 patients invited, 408 (58.5 %) returned the questionnaire (304 after the first invitation, and 104 after the reminder). A total of 333 individuals (81.6 %) completed 15D, and 345 of the respondents (84.6 %) completed EQ-5D. The difference in completion rates is not 5 NOK 500,000 equivalent with USD 89,000 (USD 1 = NOK 5.61, 2011). 6 Construct validity is measured by a scale's ability to distinguish among utility scores within one group where some respondents have a certain trait and others do not. significant. Table 2 presents differences in completion rates between 15D and EQ-5D for subgroups where the differences are significant at the 5 % level. Completion rates, in general, were higher for EQ-5D than for 15D, apart from those who were married and who did not have any problems with pain.
When investigating which attributes the respondents failed to answer (Table 3) , we found the majority of missing values in the attributes of sexual activity and symptoms/pain, in 15D. All of the respondents answered the questions regarding mobility, hearing, and vitality. In EQ-5D, we found the majority of the missing values in the Assessing quality of life in post-stroke patients 543
attributes of pain and anxiety. Relative to the other sections, there were many missing values in the attribute of usual activity in EQ-5D, compared to the corresponding attribute in 15D.
Utility scores Figures 1, 2, and 3 show the distribution of the EQ-5D and 15D scores. The Kolmogorov-Smirnov test 7 confirmed that all distributions differed from each other. However, they all had a negative skew in common. 8 We found the smallest skew in the distribution for the EQ-VAS scores. Figure 2 illustrates a consequence of the construction of the EQ-5D's value sets. It has a wide, typically discontinuous, threepeaked distribution. First, there is a large concentration at 1, and then a gap, than another concentration, followed by a third concentration, mirroring the ability to have negative values. Both of the value sets used have been constructed such that there appears a natural gap between the best illhealth state (health state profile 11211) and perfectly healthy (health state profile 11111). This is shown in the figures. Figure 4 shows a box plot of the total utility scores computed with each of the MAU instruments. The median scores clearly differ by instrument and value set; 15D has the highest median score, and EQ-VAS has the lowest. The boxes representing EQ-TTO and EQ-VAS are a lot wider than the box for 15D, indicating that the within-instrument variability is larger in EQ-TTO than in 15D, where the box is relatively small, and the variation is correspondingly moderate. We found the most outliers in EQ-TTO, while there were none in EQ-VAS, and few in 15D.
The summary statistics in Table 4 confirm the differences between scores. The mean 15D score is significantly higher than the mean EQ-VAS and EQ-TTO scores (P \ 0.0001). In addition, the mean EQ-TTO score is significantly higher than the mean EQ-VAS score (P \ 0.0001). Because the distributions of the utility scores are non-normal, we included a non-parametric test of the differences in utility scores. The signed-rank test confirmed that the differences are significant. There are large differences in minimum values and range of utility scores. EQ-TTO is particularly different from the others, due to the low negative minimum value and the wide range. It can be seen clearly that the score for 15D is higher than the scores for EQ-TTO and EQ-VAS across the 25th, 50th, and 75th quantiles of the distribution. The EQ-TTO score is higher than the EQ-VAS score across the 25th and 50th quantiles, while it is lower for the 75th quantile. The median value is higher than the mean value for all instruments, indicating that there is larger variation to the left of the median (within the lowest scores).
When investigating the mean scores across quintiles of the three different distributions, we find the same pattern. The mean 15D score is higher than the mean scores for EQ-TTO and EQ-VAS across all quintiles, except for the fifth (Table 5) . The difference between the mean scores is 7 The null hypothesis that the distributions of 15D and EQ-VAS are equal is rejected (P \ 0.0001). The hypotheses that the distributions of 15D and EQ-TTO are equal are also rejected (P \ 0.0001), and we find the same when testing the equality of the distributions of EQ-TTO and EQ-VAS. 8 The distribution of 15D has a skewness = -0.94 (P \ 0.0001), the skewness of EQ-TTO = -1.46 (P \ 0.0001), and the skewness of EQ-VAS = -0.09 (P \ 0.5).
largest in the first quintile and decreases over the higher quintiles. However, the differences in median do not decrease with the quintiles. Except for the first quintile, the EQ-TTO value is higher than the EQ-VAS value. In the fifth quintile, they are equal for both mean and median. The explanation of this is, naturally, that 23.5 % of respondents have a score of 1 in EQ-5D. Except for the fifth quintile, the smallest range of scores is in 15D. The range of EQ-VAS scores is larger than the range of EQ-TTO scores between the second and fourth quintiles.
Discriminatory power Table 6 shows the mean and median utility scores for 15D, EQ-TTO, and EQ-VAS by subgroups identified by health status and clinical indicators. Both instruments detect significant differences between those with a certain trait and those without. Thus, both can be said to have discriminatory power. However, the magnitude of the differences in utility scores varies among the instruments and value sets. For all subgroups, EQ-5D shows larger differences than 15D. In 10 out of 11 differences in mean, EQ-TTO detects larger differences than EQ-VAS. Assessing quality of life in post-stroke patients 545
Agreement and association
According to the ICC, we find fair to good agreement between 15D and EQ-TTO (ICC = 0.75). 9 The Pearson correlation indicates a strong linear relationship between 15D and EQ-5D (r = 0.80 for EQ-VAS and 15D, while r = 0.78 for EQ-TTO and 15D). Figures 5 and 6 are scatter plots of individuals' 15D scores against their EQ-TTO and EQ-VAS scores, respectively. According to these, the 15D scores seem to be more similar to the EQ-TTO scores than to the EQ-VAS scores. The figures indicate ceiling effects in EQ-5D.
Perfect health is defined with a score equal to one. According to EQ-5D, 81 (23.48 %) individuals were in perfect health, while only 25 (7.53 %) individuals were in perfect health according to 15D. This difference is statistically significant (P = 0.000). There are relatively few values at the lower end of the scales, and we found no evidence of floor effects. None of the individuals had the lowest possible scores; however, there were some negative values. The negative values occur only in EQ-TTO, while it is also possible in EQ-VAS. There is a significant variation in the number of low values. Of the 15D scores, 2.4 % are below 0.5, whereas 15.7 and 20.3 % of EQ-TTO and EQ-VAS scores, respectively, are below 0.5. Table 7 displays the regression coefficients and standard errors of the rank regression of 15D, EQ-TTO, and EQ-VAS. The coefficients show the effects of the covariates on the rank of each instrument's score. There should not be any significant differences among the coefficients from each regression if the instruments rank individuals equally after utility score. When looking at the results of EQ-TTO and 15D, we see significantly different effects from the two regressions between individuals with a poor VAS value and individuals of normal body weight. Employed individuals, those with good self-assessed health, and those with a poor VAS value have significantly different effects on EQ-VAS and 15D ranks, suggesting that individuals are not ranked similarly by the 15D and EQ-5D scores.
Rank
Discussion
EQ-5D had a slightly higher completion rate than 15D for the whole sample and for most of the subgroups, with some 
* All mean differences are significant at 1 % level, except for the differences in mean score between 15D and EQ-TTO, which are significant at the 5 % level exceptions. The main reason for this seems to be one single attribute-the attribute of sexual activity. The main reason the EQ-5D questionnaire was not completed fully seems to be the attributes of depression and anxiety. In the corresponding attributes of 15D, there are almost no missing values. The definitions of anxiety and depression are broader in 15D than in EQ-5D, which may lead to more answers. The five different levels in 15D are also more moderate and sophisticated than in EQ-5D, which may be the reason EQ-5D has so many more missing values in the attribute for usual activities, compared to the corresponding attribute in 15D. Earlier research has shown that when there is a floor or ceiling effect in one instrument and not in another, there is a weaker association between instruments at the extremes of the distribution, as well as differences in precision relative to other parts of the distribution [15] . This is not exactly the case in our study. We identified a relatively large ceiling effect in EQ-5D compared to 15D. This was kind of expected since the health classification system of 15D is finer than that of EQ-5D. However, the distributions of scores are more similar in the upper part of the distributions, while there are many more deviations at the lower end of the distributions. We did not identify any floor effects in either instrument. Nevertheless, there are large differences in how many patients scored less than 0.5. Furthermore, earlier studies have shown that the mean scores for different MAUs tend to be more similar in healthier populations than in those with higher morbidity [5] . This seems to be the case here. The differences in mean and median scores are largest in the lowest quintile, and smallest in the highest quintile. This finding suggests that the association between different instruments and value sets may differ at different points in the distribution. The large differences in the lower quintiles may be attributable to differences in the utility weights. The gap between those who are perfectly healthy and those who are almost perfectly healthy compresses the EQ-TTO scores downward. Significant differences between the 15D coefficients and the EQ-5D coefficients * P \ 0.05, ** P \ 0.01, *** P \ 0.001 (significant effects on rank)
will be large differences due to the different scoring ranges. The range of scores for the EQ-TTO can be theoretically 59 % greater (from -0.59 to 1) compared to 15D (0-1), while the difference in range between EQ-VAS and 15D can be only up to 1.1 % greater. Different scoring rods and ranges might not be a problem as long as we are aware of them. However, according to our rank regression, we found evidence that patients with different characteristics are ranked differently by the different instruments. We found more differences in ranking between 15D and EQ-VAS than between 15D and EQ-TTO. This result indicates that the scoring algorithms influence not only the scale of scores, but also how individuals are ranked after scoring. Furthermore, it suggests that there are probably more similarities between the scoring algorithms of EQ-TTO and 15D than between EQ-VAS and 15D, as they rank the individuals more similarly. Because the utility weights of both EQ-VAS and 15D are based on VAS, we expected their utility values to be closer to each other than the values of 15D and EQ-TTO. The scoring ranges between EQ-VAS and 15D are also more alike than the ranges of EQ-TTO and 15D. Nevertheless, the mean, median, and lower quartiles of EQ-TTO are closer to 15D than to EQ-VAS. Only the upper quartile of the EQ-VAS is closer to 15D than to EQ-TTO. This finding confirms that the associations among instruments and value sets differ at unique points in the distribution. In the data used for this study, the most important finding was that the scoring algorithms are more decisive for differences in utility score than in method of valuation. Note that this finding may be specific to our study.
Both instruments, irrespective of value set, distinguish between individuals with a certain trait and those without. However, EQ-TTO and EQ-VAS detects much larger differences in health utility than did 15D. The distribution of EQ-5D is skewed heavily toward the top, and the patients have, in general, higher values with 15D than with EQ-5D. 15D largely avoids ceiling effects, due to the number of possible health states. Because the utility indices derived by 15D are initially high, and there are few scores below 0.5, there may be less room for great differences between those with a certain trait and those without. This is an important finding, as health differences between individuals with a certain trait and those without, could potentially be underestimated by 15D or overestimated by EQ-5D.
Conclusion
In this study, we compared the empirical use of 15D and EQ-5D. Importantly, this investigation has demonstrated that EQ-5D and 15D cannot be used interchangeably in economic evaluations. It was determined that use of both instruments is feasible when measuring HRQoL in stroke patients. However, EQ-5D results in a slightly higher completion rate than 15D, indicating that EQ-5D is easier to use. However, because of its rich classification system, 15D appears to be more appropriate for men than for women, for those who are married, and for those without any problems with pain. EQ-5D seems to be less appropriate for individuals with depression and anxiety and problems with pain. As in earlier studies [14, [17] [18] [19] 21] , we found the utility scores of the instruments to be highly correlated, even though the instruments are scaled differently. However, it is not only the scale that differs among the instruments; the ranking of individuals after utility scoring also differs. This finding constitutes a problem for the comparability of QALY analysis, as an individual's health is probably valued very differently. When the scales from each instrument are not proportional to each other, it is not enough to adjust and standardise the scores before the QALYs are calculated. We also have to keep in mind that the differences in utility scales vary across the distributions. We found 15D to give consistently higher scores than EQ-5D, as in earlier findings. This is irrespective of the two value set we used in EQ-5D. Although there are large ceiling effects in EQ-5D, this instrument will probably detect larger health gains related to an intervention than will 15D, and it may over-or under-estimate the health benefit. We conclude that EQ-5D can potentially yield more favourable cost utility ratios than 15D. As a result of a finer classification system, all the 15D values are concentrated at the upper end of the distribution, with less room for large improvements. Further examination must be undertaken to investigate whether differences in health gains between 15D and EQ-5D are large enough to alter the results of a cost utility analysis. The use of two different value sets in EQ-5D demonstrated that the valuation method is less decisive for the different scoring scales. The construction of the scoring algorithms creates the largest differences among 15D, EQ-VAS, and EQ-TTO. Due to these differences, we must be very careful with the interpretation and comparisons of economic evaluations when these instruments are used. Furthermore, we cannot use them interchangeably. Comparisons of studies where EQ-5D is used with different value sets must also be conducted carefully, due to the diverse constructions of the scoring algorithms.
